EDITORIAL
Published on 06 Aug 2024
Editorial: Engineered medicines to mitigate resistance to cancer immunotherapy
doi 10.3389/fmed.2024.1452812
- 522 views
- Frontiers in Medicine
- Precision Medicine
- Research Topics
- Engineered Medicines to Mitigate Resistance to Cancer Immunotherapy
Engineered Medicines to Mitigate Resistance to Cancer Immunotherapy
5,339
Total downloads
24k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
SYSTEMATIC REVIEW
Published on 20 Jun 2023
Effectiveness and safety of anti-BCMA chimeric antigen receptor T-cell treatment in relapsed/refractory multiple myeloma: a comprehensive review and meta-analysis of prospective clinical trials
doi 10.3389/fphar.2023.1149138
- 3,476 views
- 8 citations
REVIEW
Published on 18 May 2023
Barriers to overcoming immunotherapy resistance in glioblastoma
doi 10.3389/fmed.2023.1175507
- 5,689 views
- 7 citations
SYSTEMATIC REVIEW
Published on 14 Apr 2023
Personalised therapeutic approaches to glioblastoma: A systematic review
doi 10.3389/fmed.2023.1166104
- 4,418 views
- 13 citations
OPINION
Published on 04 Apr 2023
Education for the translation of Advanced Therapy Medicinal Products
doi 10.3389/fmed.2023.1125892
- 2,083 views
- 4 citations
REVIEW
Published on 29 Mar 2023
Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy
doi 10.3389/fmed.2023.1135468
- 2,740 views
- 5 citations
ORIGINAL RESEARCH
Published on 23 Mar 2023
Spatial distribution of CD3- and CD8-positive lymphocytes as pretest for POLE wild-type in molecular subgroups of endometrial carcinoma
doi 10.3389/fmed.2023.1110529
- 1,749 views
- 1 citation
Published in
Frontiers in Medicine
- Precision Medicine
- Gastroenterology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Impact
- 24kTopic views
- 17kArticle views
- 5,339Article downloads